Price T Rowe Associates Inc. MD Has $481.96 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Price T Rowe Associates Inc. MD lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,164,671 shares of the company’s stock after selling 408,038 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in GE HealthCare Technologies were worth $481,955,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. Dark Forest Capital Management LP boosted its position in shares of GE HealthCare Technologies by 154.4% in the fourth quarter. Dark Forest Capital Management LP now owns 7,343 shares of the company’s stock valued at $574,000 after acquiring an additional 4,457 shares during the period. Hsbc Holdings PLC raised its stake in GE HealthCare Technologies by 10.4% during the 4th quarter. Hsbc Holdings PLC now owns 882,280 shares of the company’s stock valued at $69,022,000 after purchasing an additional 82,973 shares during the last quarter. Fayez Sarofim & Co boosted its holdings in GE HealthCare Technologies by 7.3% in the 4th quarter. Fayez Sarofim & Co now owns 9,150 shares of the company’s stock valued at $715,000 after purchasing an additional 625 shares during the period. Stifel Financial Corp grew its position in GE HealthCare Technologies by 12.8% in the 4th quarter. Stifel Financial Corp now owns 296,491 shares of the company’s stock worth $23,180,000 after purchasing an additional 33,567 shares during the last quarter. Finally, OneDigital Investment Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 110.8% during the 4th quarter. OneDigital Investment Advisors LLC now owns 29,081 shares of the company’s stock worth $2,274,000 after purchasing an additional 15,283 shares during the period. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of recent research reports. BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the stock a “buy” rating in a research report on Monday, April 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Citigroup raised their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Finally, Piper Sandler lowered their price target on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating on the stock in a report on Wednesday. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $96.50.

GE HealthCare Technologies Stock Up 3.4 %

GEHC opened at $67.08 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The firm has a market cap of $30.71 billion, a price-to-earnings ratio of 15.49, a PEG ratio of 3.19 and a beta of 1.14. The firm’s 50-day simple moving average is $77.07 and its 200-day simple moving average is $82.34. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.21%. GE HealthCare Technologies’s payout ratio is 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.